Attention Deficit Hyperactivity Disorder (ADHD) Medications and Heart Failure

Project Title Attention Deficit Hyperactivity Disorder (ADHD) Medications and Heart Failure
Date Posted
Tuesday, October 25, 2016
Status
Complete
Deliverables
Related Links
Description

Modular program-based one-time assessment of heart failure diagnoses following new attention deficit hyperactivity disorder (ADHD) medication use. The query was run against the Sentinel Distributed Database (SDD) for the time period of January 1, 2000 through March 3, 2016. Modular programs are adaptable standardized programs. Results were generated using the Cohort Identification and Descriptive Analysis (CIDA) tool, click here for more information. Queries were distributed in March 2016. These reports include data from 15 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@sentinelsystem.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from Sentinel in the public domain as soon as possible. Please read the disclaimer.

Medical Product
Strattera
amphetamine
methylphenidate
Health Outcome
heart failure
Population / Cohort
All individuals
Time Period
2000 - 2016
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER